ConductScience.org, home

Paper41563447

Targeting STAT3 by SH-4-54 suppresses the occurrence and inactivates oxidative phosphorylation in small-cell lung cancer via the SRC signaling.

Chen C and 4 others. Naunyn Schmiedebergs Arch Pharmacol, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Targeting STAT3 by SH-4-54 suppresses the occurrence and inactivates oxidative phosphorylation in small-cell lung cancer via the SRC signaling. Papers, record 41563447. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41563447

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeting STAT3 by SH-4-54 suppresses the occurrence and inactivates oxidative phosphorylation in small-cell lung cancer via the SRC signaling.
PubMed
Journal
Naunyn Schmiedebergs Arch Pharmacol
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-11-03
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen CChen
2Hu HHang
3Liu ZZhongxiang
4Jiang YYongqian
5Shi MMinhua

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
STAT3 Transcription FactorMajor topic
Lung NeoplasmsMajor topic
Small Cell Lung CarcinomaMajor topic
Antineoplastic AgentsMajor topic
src-Family KinasesMajor topic
Animals
Humans
Signal Transduction
Cell Line, Tumor
Apoptosis
Cell Proliferation
Mice, Nude
Oxidative Phosphorylation
Cisplatin
Xenograft Model Antitumor Assays
Mice, Inbred BALB C
Mice
Molecular Docking Simulation
Male

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
YCBE202213Science and Technology Bureau of Yancheng City in 2022PubMed

Source PubMed

Download CSV of grants

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131378235Current Diagnosis and Management of Small-Cell Lung Cancer.Mayo Clin Proc2019https://conductscience.org/library/papers/31378235PubMed
226649644Non-canonical Stat3 signaling in cancer.Mol Carcinog2016https://conductscience.org/library/papers/26649644PubMed
331085234Hydrogen sulphide mitigates homocysteine-induced apoptosis and matrix remodelling in mesangial cells through Akt/FOXO1 signalling cascade.Cell Signal2019https://conductscience.org/library/papers/31085234PubMed
436193770Protein tyrosine phosphatase PTPL1 suppresses lung cancer through Src/ERK/YAP1 signaling.Thorac Cancer2022https://conductscience.org/library/papers/36193770PubMed
532871210NOK associates with c-Src and promotes c-Src-induced STAT3 activation and cell proliferation.Cell Signal2020https://conductscience.org/library/papers/32871210PubMed
632466572The Crosstalk between Src and Hippo/YAP Signaling Pathways in Non-Small Cell Lung Cancer (NSCLC).Cancers (Basel)2020https://conductscience.org/library/papers/32466572PubMed
729861494Src Cooperates with Oncogenic Ras in Tumourigenesis via the JNK and PI3K Pathways in Drosophila epithelial Tissue.Int J Mol Sci2018https://conductscience.org/library/papers/29861494PubMed
825625009Protein phosphatase 2C-alpha knockdown reduces angiotensin II-mediated skeletal muscle wasting via restoration of mitochondrial recycling and function.Skelet Muscle2014https://conductscience.org/library/papers/25625009PubMed
932165236STAT3 inhibition induced temozolomide-resistant glioblastoma apoptosis via triggering mitochondrial STAT3 translocation and respiratory chain dysfunction.Cell Signal2020https://conductscience.org/library/papers/32165236PubMed
1039964764Super-enhancer-driven EFNA1 fuels tumor progression in cervical cancer via the FOSL2-Src/AKT/STAT3 axis.J Clin Invest2025https://conductscience.org/library/papers/39964764PubMed
1139995553Targeting STAT3 with SH-4-54 suppresses stemness and chemoresistance in cancer stem-like cells derived from colorectal cancer.World J Clin Oncol2025https://conductscience.org/library/papers/39995553PubMed
1236284389Asiaticoside Prevents Oxidative Stress and Apoptosis in Endothelial Cells by Activating ROS-dependent p53/Bcl-2/Caspase-3 Signaling Pathway.Curr Mol Med2023https://conductscience.org/library/papers/36284389PubMed
1311114744Role of Src expression and activation in human cancer.Oncogene2000https://conductscience.org/library/papers/11114744PubMed
1435671760Lung Cancer: Epidemiology and Screening.Surg Clin North Am2022https://conductscience.org/library/papers/35671760PubMed
1536839692Comparative Analysis of Dasatinib Effect between 2D and 3D Tumor Cell Cultures.Pharmaceutics2023https://conductscience.org/library/papers/36839692PubMed
1623807222Salinomycin induces cell death via inactivation of Stat3 and downregulation of Skp2.Cell Death Dis2013https://conductscience.org/library/papers/23807222PubMed
1729115375Persistent STAT5-mediated ROS production and involvement of aberrant p53 apoptotic signaling in the resistance of chronic myeloid leukemia to imatinib.Int J Mol Med2018https://conductscience.org/library/papers/29115375PubMed
1831069881Aminocyanopyridines as anti-lung cancer agents by inhibiting the STAT3 pathway.Mol Carcinog2019https://conductscience.org/library/papers/31069881PubMed
1935559870Impact of the National Lung Screening Trial (NLST) publication and Medicare Lung cancer screening payment on lung cancer incidence rates: An interrupted time series analysis.J Cancer Policy2022https://conductscience.org/library/papers/35559870PubMed
2035770045Aberrant ROS Served as an Acquired Vulnerability of Cisplatin-Resistant Lung Cancer.Oxid Med Cell Longev2022https://conductscience.org/library/papers/35770045PubMed

See all 54 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41563447

GET https://conductscience.org/api/papers/v1/41563447/references?page=2